{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:25:28Z","timestamp":1764743128455,"version":"3.46.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1080\/14656566.2025.2582015","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:18:36Z","timestamp":1761553116000},"page":"1741-1750","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacologic management of ET: established therapies and emerging agents"],"prefix":"10.1080","volume":"26","author":[{"given":"Rejowana","family":"Rouf","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2584-6953","authenticated-orcid":false,"given":"Douglas","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065202"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27216"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.5298"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1816082"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1720979"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0141"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013777"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0018-z"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.11.006"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.001271"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16380"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0054-y"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.277"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-695940"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444067"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009825"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-403279"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16797"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11653"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01935"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70137"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12657"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0706-x"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05764.x"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.7095"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071746"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478891"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006503.pub3"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.146654"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-359224"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279032"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504273321704"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012743"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.177"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.7026"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.139691"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.3c00092"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13265"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-443770"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043800"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05665-4"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0596"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-824315-2.00339-0"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2152-7"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.6500"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200881"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179329"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS6587"},{"key":"e_1_3_4_55_1","unstructured":"A Phase 3 Randomized Open-label Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543\/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea. 2023."},{"key":"e_1_3_4_56_1","unstructured":"Pharmaceutical I. Mutcalr & INCA033989Backgrounder*. 2025."},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"volume-title":"EHA2025. 2025, European Hematology Association (EHA) Annual Congress","author":"Mascarenhas J","key":"e_1_3_4_58_1","unstructured":"Mascarenhas J. Inca33989 is a novel, first in class, mutant calreticulin-specific monoclonal antibody that demonstrates safety and efficacy in patients with essential thrombocythemia (ET). In: EHA2025. 2025, European Hematology Association (EHA) Annual Congress; Milan, Italy."},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1548590"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000451"},{"key":"e_1_3_4_61_1","unstructured":"Harinder Gill LM Xiao Z Zhang L et al. Better safety and efficacy with ropeginterferon alfa-2b over anagrelide as second-line treatment of essential thrombocythemia in the topline results of the randomized phase 3 SURPASS-ET trial in European Hematology Association Congress. 2025."},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.2.398.398"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.34"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16744"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02008-6"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.05.002"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014791"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2582015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:21:40Z","timestamp":1764742900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2582015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":65,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["10.1080\/14656566.2025.2582015"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2582015","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"type":"print","value":"1465-6566"},{"type":"electronic","value":"1744-7666"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}